<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1472-6793-3-6.anc" start="22683" end="22687" sStart="22451" offset="232" sid="r7.1.use.v.0346" wn="1" wnkey="use%2:34:01::" annotator="jeneale" text="In light of the beneficial effect of carvedilolon the progression of heart failure, and its unique multi-actionsthat are not shared by any other ?-blocking drug or by any otheragent currently used in the treatment of heart failure, our findingsrepresent an important new mechanism of improved cardiac function." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6793-3-6.anc" start="4049" end="4055" sStart="null" offset="13" sid="r11.severe.j.0391" wn="1" wnkey="severe%5:00:00:intense:00" annotator="vebatchelder" text="Evidence for severe heart failure was markedby significantly reduced left ventricle fractional shortening (controls63." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6793-3-6.anc" start="29408" end="29412" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" annotator="cgozo" text="All authors &lt;b&gt;read&lt;/b&gt; and approved the final manuscript." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6793-3-6.anc" start="12624" end="12628" sStart="null" offset="0" sid="null" wn="3" wnkey="rate%1:07:00::" annotator="cgozo" text=",negative treppe) in failing hearts with this model [ 18 ] . This is in line with data from humanstudies, which showed that when first administered, ?-blockers actually slowheart &lt;b&gt;rate&lt;/b&gt; and diminish ejection fraction [ 27 ] .The higher dose of carvedilol significantly reduced heart &lt;b&gt;rate&lt;/b&gt; andblood pressure for up to eight hours." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6793-3-6.anc" start="12624" end="12628" sStart="null" offset="0" sid="null" wn="1" wnkey="rate%1:28:00::" annotator="brubin" text=",negative treppe) in failing hearts with this model [ 18 ] . This is in line with data from humanstudies, which showed that when first administered, ?-blockers actually slowheart &lt;b&gt;rate&lt;/b&gt; and diminish ejection fraction [ 27 ] .The higher dose of carvedilol significantly reduced heart &lt;b&gt;rate&lt;/b&gt; andblood pressure for up to eight hours." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6793-3-6.anc" start="1470" end="1475" sStart="null" offset="405" sid="r9.paper.n.0646" wn="5" wnkey="paper%1:10:02::" annotator="anfahmy" text="The initial increase in circulating norepinephrineis thought to maintain cardiac function through inotropic mechanisms.However, a direct cardiac myocyte toxicity from norepinephrine iswell recognized [ 6 7 ] . Furthermore, pressure-overloadand stretch associated release of angiotensin II has been shownto induce myocyte apoptosis [ 8 9 10 ] .In an elegant paper by Telger et al." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6793-3-6.anc" start="24760" end="24766" sStart="null" offset="56" sid="r9.normal.j.0641" wn="1" wnkey="normal%3:00:01::" annotator="veweser" text="The control group (n= 34) was maintained on a normal ration, free from any additives,and the experimental group (n = 91) was fed 700 parts per millionfurazolidone (Fz) for three weeks." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6793-3-6.anc" start="10142" end="10148" sStart="null" offset="17" sid="r9.normal.j.0624" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text=", carteolol, had normal calcium cycling, normal myocardial energetics,normal ? 1 receptor density as well as regression of myocytehypertrophy and reduced connective tissue content [ 18 ] . Furthermore, administration of carteolol hasbeen reported to prevent the development of virally induced cardiomyopathyin a murine model [ 25 ] . In a canine modelwith left ventricular dysfunction produced by multiple sequentialintracoronary microembolizations, long term treatment with metoprolol,a ? 1 -selective blocker, has been reported to preventthe progression of LV systolic dysfunction and LV chamber dilatation [ 26 ] . Similarly, our present findings onthe effect of carvedilol indicated improvement of left ventricularfunction and smaller LV volumes." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6793-3-6.anc" start="10176" end="10182" sStart="null" offset="51" sid="r9.normal.j.0532" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text=", carteolol, had normal calcium cycling, normal myocardial energetics,normal ? 1 receptor density as well as regression of myocytehypertrophy and reduced connective tissue content [ 18 ] . Furthermore, administration of carteolol hasbeen reported to prevent the development of virally induced cardiomyopathyin a murine model [ 25 ] . In a canine modelwith left ventricular dysfunction produced by multiple sequentialintracoronary microembolizations, long term treatment with metoprolol,a ? 1 -selective blocker, has been reported to preventthe progression of LV systolic dysfunction and LV chamber dilatation [ 26 ] . Similarly, our present findings onthe effect of carvedilol indicated improvement of left ventricularfunction and smaller LV volumes." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6793-3-6.anc" start="10205" end="10211" sStart="null" offset="80" sid="r9.normal.j.0230" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text=", carteolol, had normal calcium cycling, normal myocardial energetics,normal ? 1 receptor density as well as regression of myocytehypertrophy and reduced connective tissue content [ 18 ] . Furthermore, administration of carteolol hasbeen reported to prevent the development of virally induced cardiomyopathyin a murine model [ 25 ] . In a canine modelwith left ventricular dysfunction produced by multiple sequentialintracoronary microembolizations, long term treatment with metoprolol,a ? 1 -selective blocker, has been reported to preventthe progression of LV systolic dysfunction and LV chamber dilatation [ 26 ] . Similarly, our present findings onthe effect of carvedilol indicated improvement of left ventricularfunction and smaller LV volumes." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-6793-3-6.anc" start="10666" end="10670" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" annotator="cgozo" text=", carteolol, had normal calcium cycling, normal myocardial energetics,normal ? 1 receptor density as well as regression of myocytehypertrophy and reduced connective tissue content [ 18 ] . Furthermore, administration of carteolol hasbeen reported to prevent the development of virally induced cardiomyopathyin a murine model [ 25 ] . In a canine modelwith left ventricular dysfunction produced by multiple sequentialintracoronary microembolizations, &lt;b&gt;long&lt;/b&gt; term treatment with metoprolol,a ? 1 -selective blocker, has been reported to preventthe progression of LV systolic dysfunction and LV chamber dilatation [ 26 ] . Similarly, our present findings onthe effect of carvedilol indicated improvement of left ventricularfunction and smaller LV volumes." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6793-3-6.anc" start="26485" end="26491" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" annotator="veweser" text="Several cardiac cycleswere recorded on a videotape and the two dimensional &lt;b&gt;images&lt;/b&gt; subsequentlyplayed back for analysis." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6793-3-6.anc" start="26485" end="26491" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" annotator="veweser" text="Several cardiac cycleswere recorded on a videotape and the two dimensional &lt;b&gt;images&lt;/b&gt; subsequentlyplayed back for analysis." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6793-3-6.anc" start="26485" end="26491" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" annotator="jeneale" text="Several cardiac cycleswere recorded on a videotape and the two dimensional &lt;b&gt;images&lt;/b&gt; subsequentlyplayed back for analysis." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6793-3-6.anc" start="26485" end="26491" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" annotator="brubin" text="Several cardiac cycleswere recorded on a videotape and the two dimensional &lt;b&gt;images&lt;/b&gt; subsequentlyplayed back for analysis." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6793-3-6.anc" start="26485" end="26491" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" annotator="a4" text="Several cardiac cycleswere recorded on a videotape and the two dimensional &lt;b&gt;images&lt;/b&gt; subsequentlyplayed back for analysis." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6793-3-6.anc" start="26485" end="26491" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" annotator="a3" text="Several cardiac cycleswere recorded on a videotape and the two dimensional &lt;b&gt;images&lt;/b&gt; subsequentlyplayed back for analysis." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6793-3-6.anc" start="26485" end="26491" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" annotator="a2" text="Several cardiac cycleswere recorded on a videotape and the two dimensional &lt;b&gt;images&lt;/b&gt; subsequentlyplayed back for analysis." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6793-3-6.anc" start="26485" end="26491" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" annotator="a1" text="Several cardiac cycleswere recorded on a videotape and the two dimensional &lt;b&gt;images&lt;/b&gt; subsequentlyplayed back for analysis." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6793-3-6.anc" start="20653" end="20661" sStart="null" offset="746" sid="r11.function.n.0125" wn="2" wnkey="function%1:07:00::" annotator="anfahmy" text="have demonstrated that spontaneously hypertensive rats(SHR) with symptoms of heart failure had significantly higher levels ofapoptotic myocytes than control myocytes [ 37 ] .When treated with an angiotensin-converting enzyme inhibitor, thenumber of apoptotic cells in the SHR with symptoms of heart failurewas dramatically reduced to control levels; controls were SHR withoutsymptoms of heart failure [ 37 ] . Kajstura et al.have also reported that angiotensin II increased the percentageof apoptotic cells in isolated adult rat ventricular myocytes, andthis effect was mediated by AT-1 receptors [ 38 ] .Although ventricular function was not assessed in these studies,the observations raise the possibility that, like our findings withcarvedilol, the beneficial effect of ACE-inhibitors or AT-1 receptorblockers in heart failure may in part be attributed to an inhibitionof myocyte apoptosis with a resultant improvement in in vivo cardiacfunction, a concept that needs further study." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6793-3-6.anc" start="24313" end="24321" sStart="null" offset="136" sid="r11.function.n.0936" wn="2" wnkey="function%1:07:00::" annotator="adelpriore" text="The apoptotic processis linked to the development and progression of heart failure aswell as the improvement in cardiac function seen with ?-blockade." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6793-3-6.anc" start="21347" end="21355" sStart="null" offset="253" sid="r11.function.n.0609" wn="2" wnkey="function%1:07:00::" annotator="adelpriore" text="The data presented suggest that attenuation of apoptosis mayunderlie the beneficial effect of ?-blockade on ventricular function,and that the inhibition of apoptosis can possibly lead to improvementin ventricular function." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6793-3-6.anc" start="24555" end="24559" sStart="null" offset="124" sid="r7.1.easy.j.0238" wn="1" wnkey="easy%3:00:01::" annotator="jeneale" text="One day-old broad-breasted white turkey poults, obtained froma commercial breeder, were wing-banded for easy identification.At seven days of age, they were weighed and randomly divided intotwo groups using a random number generator." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6793-3-6.anc" start="3987" end="3996" sStart="null" offset="421" sid="r8.1.different.j.0835" wn="1" wnkey="different%3:00:00::" annotator="brubin" text="We have previously shown that removal of furazolidone from thefeed after three weeks results in progressive cardiac dilatationand heart failure [ 18 ] . At the time ofrandomization of the DCM group into three groups i.e., DCM 0 (notreatment), DCM 1 (lower dose carvedilol) or DCM 20 (higherdose carvedilol), fractional shortening was not different betweenthe groups (p &gt; 0.1)." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6793-3-6.anc" start="6418" end="6425" sStart="null" offset="89" sid="r10.control.n.0457" wn="4" wnkey="control%1:09:02::" annotator="veweser" text="In non-treatedDCM animals the hearts weighed significantly less than control hearts(p = 0.01)." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6793-3-6.anc" start="7446" end="7454" sStart="null" offset="119" sid="r10.control.n.0345" wn="4" wnkey="control%1:09:02::" annotator="veweser" text="Hearts from DCManimals had a significant increase in the number of TUNEL-positivecells compared to controls (5." />
  </sentences>
</list>